CT coronary angiography (CTA) with the application of 64-slice CT scanners has been increasingly used for the non-invasive identification of subclinical CAD, exclusion of morphologically focal epicardial lesions (\50% diameter stenosis) in individuals with a low-to-intermediate probability of the presence of CAD, and for 3D image fusion with SPECT or PETdetermined myocardial perfusion imaging [1] [2] [3] [4] [5] . The diagnostic value of CTA in patients with high probability of the presence of CAD or clinically manifest CAD, however, is limited due to coronary artery calcification (CAC)-induced blooming artifacts [5] . Another aspect is that the assessment of epicardial lesions still remains semiquantitative owing to limitations in spatial resolution and motion artifacts. Apart from these technical limitations, the relatively high radiation exposure for cardiovascular risk individuals during CTA has raised concerns for a more widespread clinical application [6, 7] . In this direction, however, the increasing use of prospective ECG-triggering or so called ''snap-and-shoot mode'', instead of conventional spiral image acquisition during CTA, has substantially reduced the radiation exposure of CTA from about 15-20 mSv to 1-3 mSv, while maintaining image quality and diagnostic accuracy [7, 8] . Similarly, ECG-controlled tube current modulation during helical CTA acquisition has also been shown to effectively reduce radiation exposure down to 5-7 mSv [9, 10] .
In the present issue of the International Journal of Cardiovascular Imaging, Pazhenkottil et al. [11] , report of a body surface area (BSA)-adapted contrast material (CM) protocol for CTA, which resulted in a comparable coronary contrast enhancement independent of the individual BSA. This appears to represent an elegant approach to overcome, at least in part, a known variability in contrast attenuation of the coronary vessels [12] due to CM bolus dilution depending on the blood volume of the individual during CTA. As an increase in BSA is paralleled by an increase in blood volume, the authors tested whether a BSA-adapted CM protocol could compensate for the dilution of the CM depending on the blood volume of the individual person examined with CTA. An indeed, as it was observed in the present study [11] , the range and standard deviation of the coronary attenuation were smaller in the BSAadapted protocol than in the group with standard CM protocol. These observations may suggest a well balanced and consistent attenuation of the coronary vessels throughout a large range of BSA. Whether such a BSA-adapted CM protocol results indeed in Although CTA affords a reliable assessment of coronary artery plaque burden and arterial remodeling, an accurate qualitative and quantitative characterization of coronary plaque burden and its components has remained a challenge. Plaque attenuation thresholds may vary significantly with intracoronary lumen attenuation [13] and choice of reconstruction kernels [12, 14] . The in the current study proposed BSAadapted CM protocol could be another important step in achieving a more consistent attenuation of the intracoronary lumen and, thereby, an improvement in the delineation of the arterial wall in individuals with different BSA or circulatory volume with CM dilution. On the other hand, it is equally possible that although the proposed BSA-adapted protocol achieves a more consistent attenuation of the coronary lumen as compared to a conventional rigid CM application, the intracoronary luminal contrast may not be sufficient to improve the delineation of the arterial wall as needed for imaging of coronary plaque burden. Thus, it remains a matter of ongoing research activities to define the best BSA-adapted CM protocol with an appropriate amount of CM that enables not only consistent intracoronary luminal attenuation but also an optimal delineation of the arterial wall for coronary plaque imaging. Such optimized CM protocols for CTA, as suggested by Pazhenkottil et al. [11] , may lead to a further improvement in the identification and quantitative assessment of coronary plaque burden and its components providing an important framework to evaluate but also to monitor potential beneficial effects of primary or secondary preventive medical intervention on CAD process.
